It has been also reported that the LY303511 upregulated DR4 and DR5 by activation of JNK in neuroblastoma cells, and the induction of DRs were reduced by treatment of JNK and ERK inhibitors[25]. The gene discussed is MAPK8; the disease is neuroblastoma.